Teligent Has No Explanation For Sudden Share-Price Slide

US niche generics specialist Teligent is at a loss to explain why its share price has tumbled in recent times as it ramps up production at an expanded injectables facility.

Man_Computer
Teligent is bemused by a sudden drop in its share price • Source: Shutterstock

US niche generics specialist Teligent Inc. is unable to explain why its share price suddenly plummeted below $1.00, before bouncing back to $1.03 as of midday on 15 April.

“Teligent acknowledges that there have been significant negative movements in the value of our stock over the past many days....

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Archive

More from Generics Bulletin